Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2026
Prognostic factors of non-metastatic right colon adenocarcinoma: A multicentre retrospective analysis from the ATCCR database.
СтатьяМногоцентровое исследованиеНаблюдательное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Nasri Salsabil, Chaouch Mohamed Ali, Mlouki Imen, Hassine Mohamed Ben, Bouchrika Amal, Safta Amine Ben, Blout Aya Ajmi, Hariz Emna, El Mhamdi Sana, Hassine Hiba Ben, Zouari Khadija, Nouira Ramzi
Аннотация
BACKGROUND: Right-sided colon cancer (RSCC) exhibits distinct characteristics, yet specific prognostic determinants remain insufficiently defined. This multicentre retrospective study evaluated clinicopathological and surgical factors influencing survival in a real-world cohort undergoing curative resection for non-metastatic RSCC.
METHODS: We analysed 800 adults undergoing curative-intent resection for non-metastatic RSCC across 28 centres (2018-2024). The primary outcome was 3-year overall survival (OS). Multivariate Cox model identified prognostic factors. An exploratory, post hoc subgroup analysis evaluated the impact of complete mesocolic excision (CME) on OS, stratified by tumour anatomical subsite.
RESULTS: The mean age was 62.8 years, and 24% required emergency surgery. CME was performed in 57.1% of patients, with baseline characteristics reflecting significant real-world selection bias against CME in complex clinical presentations. At 3 years (OS: 86%), multivariate analysis identified age (HR 1.071, 95% CI: 1.023-1.122, p = 0.004) and adjacent organ invasion (HR 3.642, 95% CI: 1.360-9.750, p = 0.010) as independent mortality predictors. Unadjusted post hoc analysis suggested CME was associated with improved OS for ascending colon and hepatic flexure tumours (p = 0.003).
CONCLUSION: Although CME showed an exploratory site-specific survival advantage, the critical lack of molecular profiling (MSI, RAS, BRAF) prevents adjustment for major biological confounders. Consequently, these findings are strictly hypothesis-generating, highlighting real-world surgical bias and require prospective multi-institutional validation before altering standard practice.
METHODS: We analysed 800 adults undergoing curative-intent resection for non-metastatic RSCC across 28 centres (2018-2024). The primary outcome was 3-year overall survival (OS). Multivariate Cox model identified prognostic factors. An exploratory, post hoc subgroup analysis evaluated the impact of complete mesocolic excision (CME) on OS, stratified by tumour anatomical subsite.
RESULTS: The mean age was 62.8 years, and 24% required emergency surgery. CME was performed in 57.1% of patients, with baseline characteristics reflecting significant real-world selection bias against CME in complex clinical presentations. At 3 years (OS: 86%), multivariate analysis identified age (HR 1.071, 95% CI: 1.023-1.122, p = 0.004) and adjacent organ invasion (HR 3.642, 95% CI: 1.360-9.750, p = 0.010) as independent mortality predictors. Unadjusted post hoc analysis suggested CME was associated with improved OS for ascending colon and hepatic flexure tumours (p = 0.003).
CONCLUSION: Although CME showed an exploratory site-specific survival advantage, the critical lack of molecular profiling (MSI, RAS, BRAF) prevents adjustment for major biological confounders. Consequently, these findings are strictly hypothesis-generating, highlighting real-world surgical bias and require prospective multi-institutional validation before altering standard practice.